In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Matinas Biopharma Holdings Inc (AMEX: MTNB) was $0.18 for the day, down -4.10% from the previous closing price of $0.19. In other words, the price has decreased by $-4.10 from its previous closing price. On the day, 1.37 million shares were traded. MTNB stock price reached its highest trading level at $0.195 during the session, while it also had its lowest trading level at $0.1755.
Ratios:
Our analysis of MTNB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.93 and its Current Ratio is at 5.93. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.15.
On January 27, 2020, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $3.Piper Sandler initiated its Overweight rating on January 27, 2020, with a $3 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MTNB now has a Market Capitalization of 45146880 and an Enterprise Value of 30621528. For the stock, the TTM Price-to-Sale (P/S) ratio is 41.04 while its Price-to-Book (P/B) ratio in mrq is 2.03. Its current Enterprise Value per Revenue stands at 27.939 whereas that against EBITDA is -1.31.
Stock Price History:
The Beta on a monthly basis for MTNB is 1.64, which has changed by -0.72793055 over the last 52 weeks, in comparison to a change of 0.2006725 over the same period for the S&P500. Over the past 52 weeks, MTNB has reached a high of $0.89, while it has fallen to a 52-week low of $0.11. The 50-Day Moving Average of the stock is -27.22%, while the 200-Day Moving Average is calculated to be -23.20%.
Shares Statistics:
MTNB traded an average of 1.54M shares per day over the past three months and 776530 shares per day over the past ten days. A total of 250.82M shares are outstanding, with a floating share count of 243.50M. Insiders hold about 2.92% of the company’s shares, while institutions hold 10.32% stake in the company. Shares short for MTNB as of 1711584000 were 3274618 with a Short Ratio of 2.12, compared to 1709164800 on 1469957. Therefore, it implies a Short% of Shares Outstanding of 3274618 and a Short% of Float of 1.55.
Earnings Estimates
The stock of Matinas Biopharma Holdings Inc (MTNB) is currently in the spotlight, with M&T Bank Corporation analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is $0.18, with high estimates of $9.31 and low estimates of $202.65.
